
MeAgain is the GLP-1 plotter for people who want to see where their weekly semaglutide or tirzepatide shot sits right now, not just remember when they took it. A semaglutide shot hangs around for about 1 week, while tirzepatide tapers a little faster at about 5 days, so the way the week feels can shift day by day. MeAgain turns that invisible curve into a medication graph that updates after each logged shot, then connects it to the next-dose countdown, the weekly checklist, the last injection site you used, side effects, and food or water tracking. The result is not just a chart. It is a readable weekly story. MeAgain has 372,000+ users and a 4.8-star App Store rating across over 17,000 ratings. The app is $10/month, and eligible subscribers can use the in-app intake for self-pay semaglutide at $129/month or self-pay tirzepatide at $199/month through US-based 503A and 503B pharmacies after licensed clinician approval.
Semaglutide hangs around for about 1 week and tirzepatide about 5 days, so the week feels different depending on the molecule. MeAgain's GLP-1 plotter turns that invisible curve into a medication graph you can actually read after every logged shot.
Official prescribing information says semaglutide typically reaches maximum concentration 1 to 3 days after a dose, while tirzepatide reaches it in 8 to 72 hours. The plotter helps you see where you are between that peak window and next-shot day.
MeAgain pairs the plotter with the rest of the app: 372,000+ users, 4.8 stars, over 17,000 ratings, plus the weekly checklist, injection-site history, side effects, five food logging methods, and the home screen widget.
The graph is most useful when it sits next to real life signals. MeAgain lets you compare the weekly curve with hunger, meals, water, protein, constipation, nausea, and the next-dose countdown instead of staring at an isolated chart.
The app is $10/month, and eligible subscribers can start self-pay semaglutide at $129/month or self-pay tirzepatide at $199/month through US-based 503A and 503B pharmacies. If the molecule changes later, the plotter and the rest of your history stay intact.

The plotter shows the weekly rise and fall of semaglutide and tirzepatide after each logged shot. That matters because a weekly GLP-1 is not flat across the full week. Semaglutide hangs around for about 1 week. Tirzepatide tapers a bit faster at about 5 days. The first couple of days after a shot can feel different than day 6 or day 7, and the graph makes that shift visible instead of leaving it to memory. MeAgain updates the weekly curve automatically when you log the date and dose, so you can see where it is right now, when it is likely near its peak, and how far you are from the next shot. That clear weekly view is why people open a plotter in the first place.

A GLP-1 plotter only works if the shot log is clean. MeAgain keeps the weekly graph tied directly to the logged dose, date, and shot history, so the curve stays grounded in what actually happened rather than what you think happened last Thursday. The weekly checklist helps you confirm the routine, the next-dose countdown shows how long is left before the next injection, and the injection-site log keeps the shot history grounded too. That is why the plotter in MeAgain feels more useful than a generic calculator. It is not a one-time estimate you visit once. It is part of the weekly routine, and every new shot automatically updates the curve and the rest of the treatment view.

The graph gets much more useful when it is placed beside the rest of the week. A chart alone might tell you where the medication sits, but it cannot explain why your hunger changed, why nausea was louder on one day than another, or why the week felt easier once protein and water came back up. MeAgain connects the plotter to side effect logging, five food logging methods, and daily water, protein, and fiber tracking so the weekly curve has context. That lets you compare the shape of the chart with how the week actually felt in your body. Maybe appetite was loudest when the curve was lowest. Maybe constipation was worst right after a dose increase. The chart becomes much more useful when it helps you spot patterns you can actually use.

The weekly curve works best when it lives inside the rest of your tracker instead of on a separate calculator screen. MeAgain keeps weight, meals, water, protein, side effects, shot dates, and the weekly curve in one timeline, which is why the plotter keeps mattering long after the first week of curiosity. That also means the graph still works if your doctor changes the molecule later. If you move from semaglutide to tirzepatide, or the other way around, the history stays intact and only the treatment settings change. MeAgain makes money from the $10/month app subscription, not from medication markup, so the graph stays an app feature first and the optional self-pay medication path remains a subscriber benefit inside the same experience.
A GLP-1 plotter is not a blood test. It is a mathematical estimate of how a weekly shot rises and fades over time based on published half-life and absorption data. For semaglutide, official prescribing information says maximum concentration is typically reached 1 to 3 days after a dose, the elimination half-life is about 1 week, and steady state is reached after roughly 4 to 5 weeks of once-weekly dosing. For tirzepatide, the time to maximum concentration is 8 to 72 hours, the elimination half-life is about 5 days, and steady state is reached after about 4 weeks. That is what the graph is trying to make visible. The long-term point is consistency: STEP-1 followed semaglutide users for 68 weeks and SURMOUNT-1 followed tirzepatide users for 72 weeks. A weekly chart is useful because these medications work across many months, not just one shot.
| Medication | Approx half-life | Typical peak after dose | Steady state |
|---|---|---|---|
| Semaglutide weekly shot | About 1 week | 1 to 3 days | 4 to 5 weeks |
| Tirzepatide weekly shot | About 5 days | 8 to 72 hours | 4 weeks |
MeAgain makes money from the $10/month app subscription. That's it. That is why the GLP-1 plotter lives in the app itself and keeps working whether you stay on semaglutide, move to tirzepatide, or use the optional self-pay path inside the app. Eligible subscribers can request compounded semaglutide at $129/month or compounded tirzepatide at $199/month, both dispensed through US-based 503A and 503B pharmacies. Whichever weekly shot you and your doctor choose, the plotter is already there and the full timeline stays intact.
This content is for informational purposes only and does not constitute medical advice. The GLP-1 plotter shows a mathematical estimate, not an actual blood level measurement. Dose changes and medication decisions should be made with your doctor or licensed clinician.
Sources
People looking for a GLP-1 plotter usually want more than a static chart. They want to see the curve and understand the rest of the week around it. One App Store reviewer put it this way:
I loved being able to track my weight, shots, water intake, fiber and protein all in one easy place! I enjoyed being able to see the mg that were in my system hour by hour as well!
That is the appeal of MeAgain. The graph is easy to open, but it gets much more useful when it lives next to the rest of the tracker instead of floating alone as a calculator.
The medication graph sits next to the next-shot countdown, the weekly checklist, meals, water, protein, side effects, and the weight trend, so the curve always has context. That is why the plotter stays useful after the first glance and why the same app still works if your doctor changes the weekly shot later.

“I loved being able to track my weight, shots, water intake, fiber and protein all in one easy place! I enjoyed being able to see the mg that were in my system hour by hour as well!”
“Love it! It helps me keep track of my intake of protein, water and fiber which I was struggling with. I love that on shot day it has a check list.”
“I love this app. It really helps to keep me motivated and keep track of my progress. I never saw the appeal of tracking apps until I found this one. It's also adorable to have Capy in my widgets.”
“My daily goal is to make sure I don't make my capybara cry.”
“As a girly on a new GLP-1 journey, this app has been such a fun way to track my dosing, symptoms, meals, water, steps and more! The Capy widget is a favorite.”
A GLP-1 plotter is a graph that estimates where your weekly medication sits between shots instead of leaving the week invisible. In MeAgain, the plotter uses your logged shot date and dose together with published half-life data to draw a weekly curve for semaglutide or tirzepatide. The purpose is not to claim a lab value. It is to make the week readable. That matters because weekly GLP-1s are not flat from day 1 to day 7. The first days after a shot often feel different from the last days before the next one. MeAgain connects the graph to the next-dose countdown, the weekly checklist, side effects, food, water, and the weight trend, so the plotter functions as part of the full daily tracker rather than as a disconnected tool.

Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.